Roger E. Wyse

President and Chief Operating Officer, Burrill Biogreentech Venture and Private Equity Funds

Roger E. Wyse joined Burrill & Company in 1998 and has led the development of its agriculture, nutraceuticals, health and wellness, and biogreentechrelated activities in venture capital investing, and merchant banking.

Dr. Wyse is an internationally recognized scientist and was a Dean at two major research universities. He served for five years as Dean of the College of Agricultural and Life Sciences at the University of Wisconsin-Madison. From 1986 to 1992 he served as Dean of Research at Rutgers University. Throughout his administrative career Dr. Wyse has been known for  his vision and leadership in developing national policies and funding for life sciences research. Dr. Wyse chairs or serves on the boards of six private companies: Attune, Brand Accelerator (Chair), Chakra Biotech (Chair), Corazonas (Chair), Efficas, and Segetis. He is Co-Chairman of the Malaysian Life Sciences Capital Fund; and is a member of the International Advisory Panel for Biotechnology (BioIAP) for the Prime Minister of Malaysia. He was founder and Chairman of the Alliance for Animal Genome Research. He is also on the board of the industry group BIO and on the executive committee of BIO’s Industrial and Environmental Section. In research, Dr. Wyse earned international recognition for his basic studies in plant biochemistry.

He has published more than 150 scientific papers. In recognition of his research accomplishments he received the prestigious Arthur Flemming Award in 1982 as the Outstanding Young Scientist in the U.S. Federal Service. He was elected a Fellow of both the Crop Science Society of America and The American Society of Agronomy. And in 2008, he was elected as a Fellow of The American Association for the Advancement of Science. He has also served as a consultant to numerous Fortune 500 companies.